Spontaneous tibioperoneal trunk and anterior tibial artery pseudoaneurysms.

Aneurysms of the tibioperoneal trunk and anterior tibial artery are extremely rare. There are only a few case reports of this entity, for which the majority are secondary to prior trauma or bacteremia and endocarditis. We describe a case of spontaneous pseudoaneurysms of the right anterior tibial artery and tibioperoneal trunk.

Durability of renal artery stents in patients with transrenal abdominal aortic endografts.

Objective: The management of renal artery stenosis in patients with abdominal aortic aneurysms continues to be complex and technically challenging despite advances in endovascular therapy. There is growing concern about the durability of renal artery stents in the setting of transrenal abdominal aortic endografts. This study reports a single-center experience of renal artery stenting with transrenal abdominal aortic endografts for patients with renal artery stenosis.

Endovascular treatment of failed prior abdominal aortic aneurysm repair.

Failure of endovascular or conventional abdominal aortic aneurysm (AAA) repair may occur as a result of attachment site endoleak (type I) or paraanastomotic aneurysm and pseudoaneurysm formation. This study examined the results of the use of secondary endovascular grafts for the treatment of failed prior infrarenal AAA repair procedures. Forty-seven patients were treated with endovascular grafts.

Mechanical failure of prosthetic human implants: a 10-year experience with aortic stent graft devices.

Objective: The first endovascular stent graft was implanted to treat an abdominal aortic aneurysm more than a decade ago. This technique has evolved dramatically with the growing understanding of metallurgic and fabric sciences and improved device designs. However the potential for stent graft material failure remains.

A multicenter experience with the Talent endovascular graft for the treatment of abdominal aortic aneurysms.

Objective: The Talent endovascular graft has been used in the treatment of abdominal aortic aneurysms (AAAs) in more than 13,000 patients worldwide. However, information regarding the results of its use has been limited. This report describes the experience with 368 patients with AAAs who underwent treatment at four medical centers as part of an investigator-sponsored investigational device exemption trial.